Life sciences

#BioInnovation Institute #Biologics / Biotechnology #Biotech hubs #Drug discovery #Funding #Investment #Life sciences #Market reporting #Start-ups #United States

New podcast: Global epicentres of drug discovery innovation

This is the latest episode of the free DDW narrated podcast, titled “Where are the global epicentres of drug discovery innovation?”, which covers two articles written for DDW Volume 24 – Issue 2, Spring 2023 of DDW. They are called: Where are the hottest drug discovery hubs in the… Read More

#News

EU flag
#EU Health Coalition #Europe #Life sciences

Life sciences must be a priority in the next EU budget, urges Coalition

For Europe to remain relevant and competitive, it must make health and the life sciences sector a central pillar of the next Multi Annual Financial Framework (MFF), according to the EU Health Coalition.  The Coalition emphasises that with a strategic focus on health in the MFF, Europe… Read More

#News

#Astex Pharmaceuticals #Bioorthogonal chemistry #Click chemistry #Cognitive impairment #Covid-19 #Drug discovery #Life sciences #Long Covid #Molecular Biology #Neuroscience #Public health

Podcast: Innovative approaches to improving drug discovery

This is the latest episode of the free DDW narrated podcast, titled “Innovative approaches to improving drug discovery”, which covers three articles written for DDW Volume 24 – Issue 2, Spring 2023 of DDW. They are called: Post-Covid cognitive impairment: a new target for drug development?, Sitting Down… Read More

#News

#Cancer research #Drug development #Drug discovery #Immune system #Immunotherapy #Life sciences #Lithuania #Oncology #Start-ups #Tumour biology #Tumours

New podcast: Exciting start-ups and developments in drug discovery

This is the latest episode of the free DDW narrated podcast, titled ‘Exciting start-ups and developments in drug discovery’, which covers two articles written for DDW Volume 24 – Issue 1, Winter 2022/2023. They are called: ‘What Lithuania offers life sciences start-ups’ and ‘… Read More

#News

#Drug development #Investment #Life sciences #Treehill Partners #US government

Expert opinion on life sciences in a Trump/RFK era

Max Baumann, Co-Founder and Head of Execution of Treehill Partners, discusses what investors, drug developers, and the rest of the life science sector can do to prepare for the Trump/RFK era. The arrival of a new US administration generates significant industry-wide speculation and anticipation regarding new policies and agendas that may… Read More

#Business & Investment #Exclusive Content #Opinion

Downing Street, London, UK
#ABPI #Association of the British Pharmaceutical Industry #Life sciences #NHS #The King's Fund #UK government

Strong leadership needed for UK life sciences industry success

Health and care researchers at The King’s Fund are calling for the UK government and national NHS leaders to play a greater role in developing guidance and providing leadership of health service partnerships with the life sciences industry.   The UK has a large and thriving life… Read More

#News

#Drug discovery #Investment #Life sciences

Podcast: Investment trends for drug discovery and development

In the In Conversation With series, a part of the free DDW podcast, DDW speaks with members of the drug discovery industry about their work and how it helps turn science into business.    In this episode, Megan Thomas is in conversation with Owen Smith, Partner at… Read More

#News

#4BIO Capital #Drug development #Drug discovery #Investment #Life sciences

New podcast: Investment trends for drug discovery and development

In the In Conversation With series, a part of the free DDW podcast, DDW speaks with members of the drug discovery industry about their work and how it helps turn science into business.    In this episode, Megan Thomas is in conversation with Owen Smith, Partner at… Read More

#News

Great British Pounds, Investment
#ABPI #Life sciences #UK budget #UK economy #UK government

UK Chancellor backs life sciences in the Budget

The UK’s Labour Government has announced its first budget, which focuses on stability, investment, and long-term growth. Key announcements in the Budget included increases in NHS funding, a £520m life sciences innovative manufacturing fund, and investment in research and development, including increased funding for the National… Read More

#News #Trending News

#Association of the British Pharmaceutical Industry #Life sciences #UK budget #UK economy #UK government

Calls for life sciences and new medicines support in UK Budget

With a new UK Budget looming on 30 October, the first of this new Labour government, the Chancellor has been urged to protect the country’s life sciences sector and increase investment in medicines. Concerns have been raised in response to rumours of potential cuts to UK… Read More

#News

#Contract Research Organisations (CROs) #Discovery Park #Life sciences #Pfizer #Start-ups

Three new life science start-ups join Discovery Park

A group of former Pfizer employees have created their own businesses based at and supported by Discovery Park, a life sciences community in Kent, UK. The new businesses are all contract research organisations (CROs), namely Biowaived, Matheus Engineering and Particology. Their launch has been supported by… Read More

#Business & Investment #News #Start-up Zone

Discovery Park Kent
#Business #Discovery Park #Life sciences

Applications open for Discovery Park’s ‘Discovery Spark’ programme

Science and innovation campus, Discovery Park, in Sandwich, UK, has launched applications for the third stage of its business growth competition, ‘Discovery Spark’. The programme aims to equip early-stage life science and technology companies with business skills and tools, refine their commercial strategy and achieve investor… Read More

#Business & Investment #News

#Life sciences #Novo Nordisk Foundation #Regenerative Medicine #Stem cells

The future of regenerative medicine at Novo Nordisk Foundation

Recently, the Novo Nordisk Foundation updated its strategy to include regenerative medicine. While regenerative medicine is not new to the Foundation, it is now an explicit part of the company’s strategy. DDW’s Megan Thomas caught up with Martin Ridderstråle, Senior Vice President and Head of Medical Science at the… Read More

#Business & Investment #Exclusive Content

Drug discovery innovation
#AAV #Cell and gene therapy #Drug development #Drug discovery #Gene therapy #Genetics / genomics #Immunology / Virology & Vaccines #Interview #Life sciences #Market reporting #Precision medicine #RNA #RNA sequencing #Scandinavia #Sweden #Transcriptomics

Podcast: Innovation drivers and opportunities for drug discovery

This is the latest episode of the free DDW narrated podcast, titled “Innovation drivers and opportunities for drug discovery”, which covers three articles written Volume 24 – Issue 1, Winter 2022/2023 of DDW. They are called: Optimising AAV capsid purification through improved analytics How… Read More

#News

Image of the earth showing the UK and Scandinavia
#ABPI #Drug discovery #Investment #Life sciences #Medicines Discovery Catapult (MDC)

Why the UK needs to nurture a fit-to-fund life sciences sector 

Professor Chris Molloy, CEO of Medicines Discovery Catapult (MDC), writes about the state of the UK’s drug discovery sector, exploring economic challenges and what is needed to support the country’s rich life sciences talent.   We should all be proud of and inspired by the UK life… Read More

#Exclusive Content